Ernst Kubista

Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients. Austrian Breast Cancer Study Group.

M. Gnant, R. Zeillinger, H. Samonigg, 1999, European journal of cancer.

Co-Expression of ErbB-Family Members in Human Breast Cancer: Her-2/neu is the Preferred Dimerization Candidate in Nodal-positive Tumors

E. Kubista, C. Singer, G. Hudelist, 2003, Breast Cancer Research and Treatment.

Differential spatial expression and activation pattern of EGFR and HER-2 in human breast cancer.

E. Kubista, C. Singer, D. Gschwantler-Kaulich, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer.

M. Gnant, H. Samonigg, R. Jakesz, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer.

M. Gnant, H. Samonigg, R. Jakesz, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Estetrol, a pregnancy-specific human steroid, prevents and suppresses mammary tumor growth in a rat model

E. Kubista, A. Genazzani, T. Simoncini, 2008, Climacteric : the journal of the International Menopause Society.